GLP-1 coverage in Ontario

Not on its own. OHIP does not pay for prescription drugs. The Ontario Drug Benefit pays for Ozempic only as a Limited Use benefit for type 2 diabetes, and Wegovy for weight management is not a benefit. OHIP+ follows the same list.

Coverage in Ontario

  • Ontario Drug Benefit · Ozempic

    Partial coverageLimited Use (LU 665, 666, 667): type 2 diabetes when metformin at the maximum tolerated dose hasn't controlled blood sugar, or isn't suitable. Not funded otherwise.Checked 3 Oct 2026 · plan document dated 26 Jan 2024 Source
  • Ontario Drug Benefit · Wegovy

    Not coveredListed as Off-Formulary Interchangeable since 31 Aug 2026. The record shows no amount paid by the Ministry of Health.Checked 3 Oct 2026 · plan document dated 31 Aug 2026 Source
  • Ontario Drug Benefit (generic semaglutide) · Ozempic

    Partial coverageApo-Semaglutide (DIN 02568020, 02568012) and Dr. Reddy's Semaglutide Injection (02567806, 02567814) listed 30 Jun 2026 as interchangeable with Ozempic under its Limited Use criteria.Checked 3 Oct 2026 · plan document dated 30 Jun 2026 Source
  • Ontario Drug Benefit · Rybelsus

    Partial coverageLimited Use (LU 738, 739, 740 for 1.5 mg, 4 mg, 9 mg tablets): adult type 2 diabetes not controlled on maximum tolerated metformin, or metformin contraindicated or inappropriate. Not funded with injectable semaglutide.Checked 3 Oct 2026 · plan document dated 31 Mar 2026 Source
  • Ontario Drug Benefit (Sevmia) · Wegovy

    Not coveredSevmia 4mg/3mL (DIN 02569582, Apotex) listed 31 Aug 2026 as an Off-Formulary Interchangeable of Wegovy: substitutable by pharmacists, not a formulary benefit.Checked 3 Oct 2026 · plan document dated 31 Aug 2026 Source
  • Canada Life employer plans · Wegovy

    Partial coveragePrior authorization form; Wegovy not covered under all benefit plans; asks for 3-6 months of unsuccessful diet/exercise and a BMI threshold.Checked 3 Oct 2026 · plan document dated 1 Mar 2026 Source

What the public plan in Ontario pays for

Ontario’s public drug plan is the Ontario Drug Benefit (ODB). It pays most of the cost of drugs on its formulary, the list of drugs the plan agrees to pay for. OHIP, the health insurance on your health card, covers doctor and hospital care but not prescription drugs at the pharmacy counter.

The ODB is not open to everyone. You qualify automatically at age 65, and younger people qualify if they live in long-term care, get home care, or receive Ontario Works or disability support benefits. OHIP+ and the Trillium Drug Program are the two other routes in, covered below.

Ozempic is a limited-use benefit

Ozempic is listed as a Limited Use (LU) benefit, meaning the ODB pays only when you meet written conditions. The criteria are for adults with type 2 diabetes whose blood sugar is not controlled on the maximum tolerated dose of metformin, or for whom metformin is not suitable. Semaglutide is not funded together with another GLP-1 drug or a DPP-4 inhibitor, and injectable and oral semaglutide are not funded together.

Your prescriber puts an LU code on the prescription. The three Ozempic pens were listed with codes 665, 666 and 667 when the status changed on 31 January 2024. The ministry says claims for people who don’t meet the criteria are recovered from the pharmacy.

We mark this partial, because the plan pays only when the criteria are met. It does not pay for Ozempic used for weight management.

Generic semaglutide and Rybelsus

The June 2026 formulary update, effective 30 June 2026, lists Apo-Semaglutide and Dr. Reddy’s semaglutide injection as interchangeable with Ozempic, each tied to the matching Ozempic pen. They follow the Ozempic Limited Use criteria. Our generics page shows the products and their Health Canada status.

The March 2026 update, effective 31 March 2026, listed Rybelsus tablets (oral semaglutide) as Limited Use with codes 738, 739 and 740 for the 1.5 mg, 4 mg and 9 mg tablets. The criteria match Ozempic’s: type 2 diabetes not controlled on metformin, or metformin not suitable.

Wegovy and its generic are not ODB benefits

Wegovy, the semaglutide product approved for chronic weight management, is not an ODB benefit. The e-formulary lists it as an off-formulary interchangeable (OFI). An OFI product is one the ministry has judged interchangeable with a brand that is not a benefit, and the formulary states that none of the products in that part are benefits.

The August 2026 update, effective 31 August 2026, added Apotex’s Sevmia, the generic Wegovy, to the same off-formulary list. A pharmacist can substitute it for Wegovy, but the ODB does not pay for either one. We mark both not covered.

Mounjaro, Zepbound and Saxenda in Ontario

Not yet confirmed. The ODB update summaries we read, from October 2025 through September 2026, don’t mention tirzepatide or liraglutide, and we couldn’t open an e-formulary page that shows their status. We won’t guess. Ask your pharmacist to check the product’s DIN, or search the formulary yourself.

OHIP+ for people aged 24 and under

OHIP+ covers people aged 24 and under who have OHIP and no private drug plan. It pays for drugs available through the ODB, and coverage ends on your 25th birthday. Because it uses the ODB list, Ozempic under OHIP+ has the same Limited Use criteria and Wegovy has no OHIP+ funding. You don’t enrol, and you only need a health card number and a valid prescription.

If you are under 25 and have a private plan, you aren’t eligible for OHIP+.

Trillium and the exceptional access route

The Trillium Drug Program is for people whose prescription costs are high compared with their household income. You pay a deductible, usually about 4% of your after-tax household income, split into quarters, and then a small fee per fill. It covers drugs available through the ODB, so it doesn’t open up drugs the formulary leaves out.

The Exceptional Access Program (EAP) is the case-by-case route for drugs not on the formulary. Your prescriber applies, and you must already be eligible for an ODB funding program. We haven’t found a published EAP position for Wegovy, so we don’t state one.

If you have a private plan

Many Ontarians get drug coverage through work. Private plans decide for themselves, and some ask for prior authorization for GLP-1 drugs. See coverage across Canada for what two insurers publish. For what you would pay at the counter, see Ozempic prices in Ontario and Wegovy prices in Ontario.

If you want a prescriber online, compare providers by care model.

Questions people ask

Is Ozempic covered by OHIP+?

OHIP+ pays for drugs on the Ontario Drug Benefit list for people aged 24 and under who have no private plan. Ozempic is on that list as Limited Use, so the same type 2 diabetes criteria apply.

Is Wegovy covered in Ontario?

Not by the Ontario Drug Benefit. The formulary lists Wegovy as an off-formulary interchangeable, which is not a benefit. A private plan may cover it, depending on the plan.

Does the Ontario Drug Benefit pay for generic semaglutide?

Yes, for two products. Apo-Semaglutide and Dr. Reddy's semaglutide were listed on 30 June 2026 as interchangeable with Ozempic, under the same Limited Use criteria.

What is a Limited Use code?

It is a code your prescriber writes on the prescription to show you meet the formulary's conditions for that drug. If you don't meet them, the Ontario Drug Benefit does not pay.

Can the Trillium Drug Program help with Ozempic?

Trillium helps people whose drug costs are high compared with their household income. It covers drugs available through the Ontario Drug Benefit, so Ozempic still has to meet its Limited Use criteria.

Other medications in Ontario